🌸 Springtime – where flowers and ideas bloom! Whether you’re chasing big questions or exploring tiny molecules, our #nanobody tools & custom #sdAb services help you make egg-cellent progress. 🐣🔬🦙

Wishing you flourishing research and plenty of hoppy moments 🐇!

#HappyEaster from #NanoTag!

Meet #NanoTag at the #FOM2026 in Stockholm!
Visit booth 24 to explore our 🦙 #nanobody -based solutions tailored for quantitative super-resolution microscopy and flexible #multiplexing 🔬.

Our team is looking forward to connecting with you!

#SingleDomainAntibodies
#SmartSecondaries #FluoTag

Join #NanoTag team at #FOM2026 in Stockholm 🇸🇪!

Visit booth #24 to see how our single-domain antibody (sdAb) technologies bring greater precision to #microscopy and more flexibility & ease to #multiplexing 🔬

See you in Stockholm! 👋

#SuperResolution #Nanoscopy
#Nanobody #Immunofluorescence

Did you know #multiplex IF can be done in just one incubation step?

❌ No sequential staining
❌ No host-species limits
❌ No secondary-induced clustering

🔬Pre-mix your favourite primary antibodies (even same-species) with Smart Secondaries® #nanobody & apply directly to your sample for OneStep IF.🤩

Heading to #BPS2026 in San Francisco?

Visit NanoTag team at booth 720 to explore our single-domain antibody #sdAb tools: ALFA® System, FluoTags®, Smart Secondaries® & Selector Resins.
See you! 👋

@biophysicalsoc.bsky.social
#Nanobody #Multiplexing
#SuperResolution #Microscopy
#AffinityPurification

Did you know? #NanoTag offers custom single-domain antibody (sdAb) discovery services, including alpaca immunization🦙and synthetic library–based approaches🧬backed by over a decade of experience in the field 💪.

Discuss your project with our experts: nano-tag.com/contact/

#CRO #Nanobody #VHH #sdAb

Targeting CD155 in lung adenocarcinoma with a nanobody-based therapy
A5 nanobody targeting CD155 shows promise for selective therapeutic intervention in lung adenocarcinoma.
doi.org/10.1038/s413...
#LungAdenocarcinoma #Nanobody #CD155 #CancerTherapeutics

Machine learning enables efficient and effective affinity maturation of nanobodies Antibodies can bind their targets with exquisite potency and selectivity due in part to large antibody-target protein-protein interaction surface areas. Despite the ...

IPI teamed up with @deboramarks.bsky.social & Andrew Kruse @harvardmed.bsky.social to design optimized #nanobody binders using #ML on single-sort sequencing data. The approach could speed discovery by reducing the need for multi-sort #affinitymaturation.

Read more:

CD38-specific nanobody-based bispecific antibody recruiters (BARs) redirect complement-dependent cytotoxicity toward multiple myeloma cells - Scientific Reports Bispecific antibody recruiters (BARs) are an innovative class of immunotherapeutics that redirect endogenous antibodies to tumor cells. BARs comprise a tumor-binding and an antibody-binding module, en...

Amazing publication from the THUNDER lab at UKE, which is also part of our consortium!
It's about a new class of engagers for the treatment of multiple myeloma.🧑‍🔬🤯🤩 #sciencerocks #CD38 #nanobody
www.nature.com/articles/s41...

Last year, my group launched a project funded by the T. von Zastrow Foundation that truly took all of us into new territory: the establishment of our own #Nanobody Discovery Platform. We genuinely started from scratch – including setting up our own alpaca facility with five female alpacas…

Investors Urged to Act as MoonLake Faces Lawsuit After Massive Stock Drop and Nanobody Controversy Investors of MoonLake Immunotherapeutics are reminded of the upcoming deadline for a securities class action lawsuit. Major claims surrounding its Nanobody technology face scrutiny after a staggering stock decline.

Investors Urged to Act as MoonLake Faces Lawsuit After Massive Stock Drop and Nanobody Controversy #United_States #San_Francisco #Hagens_Berman #MoonLake #Nanobody

Proposed mechanism of receptor-dependent activity of bitopic ligands. Structures of PTHR1 and A2AR used in this panel were generated using Alphafold2.

Bitopic ligands comprise a #pharmacophore & a linked moiety that bind to separate sites. @rche54.bsky.social &co show that #GPCRs that bind small molecules can be potently activated by #bitopic #nanobody -ligand conjugates to selectively target pairs of GPCRs @plosbiology.org 🧪 plos.io/4p3VOyH

Proposed mechanism of receptor-dependent activity of bitopic ligands. Structures of PTHR1 and A2AR used in this panel were generated using Alphafold2.

Bitopic ligands comprise a #pharmacophore & a linked moiety that bind to separate sites. @rche54.bsky.social &co show that #GPCRs that bind small molecules can be potently activated by #bitopic #nanobody -ligand conjugates to selectively target pairs of GPCRs @plosbiology.org 🧪 plos.io/4p3VOyH

Proposed mechanism of receptor-dependent activity of bitopic ligands. Structures of PTHR1 and A2AR used in this panel were generated using Alphafold2.

Bitopic ligands comprise a #pharmacophore & a linked moiety that bind to separate sites. @rche54.bsky.social &co show that #GPCRs that bind small molecules can be potently activated by #bitopic #nanobody -ligand conjugates to selectively target pairs of GPCRs @plosbiology.org 🧪 plos.io/4p3VOyH

Attending #CellBio2025 in Philadelphia Dec 6–10?
Visit #NanoTag team at booth #1117 to explore our #sdAb technologies & ready-to-use reagents: ALFA® System, FluoTags®, Smart Secondaries®, Selector Resins.
See you there! 👋 @ascbiology.bsky.social

#Nanobody #CellBiology
#Immunofluorescence #PullDown

Join our CTO, Felipe Opazo @opazo.bsky.social, at #MBSJ2025 @mbsj-official.bsky.social as he presents new super-resolution #multiplexing advances powered by #SmartSecondaries®.
🔬Discover flexible, scalable and precise multi-target imaging.

#Nanobody
#NanoPlex #SUMPAINT
#SuperResolution #Microscopy

💪 Small in size, strong in performance
Anti-PD-L1 VHH Antibody (JOT0002-5) by Jotbody: precise PD-L1 detection (ELISA/WB/IHC/IF/FC), 14.4 kDa, KD=0.363 nM. Ideal for research & diagnostics.
#PDL1 #VHH #nanobody #lifescience #biotech #researchtools

Dr. Yan Li from #USTC #Hefei #China talks on therapy for #Hepatocellular #Cancer / #HCC. #CXCR1 #nanobody approach to treat HCC & other cancer types. Focused on effects on NK cells. CXCL8 is the ligand. #WIC2025 #SITC2025

Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites - Nature A recombinant antivenom composed of eight nanobodies provides broad protection against venom-induced lethality and dermonecrosis in mice challenged with venoms from cobras, mambas and rinkha...

Read more in the linked post, or access the paper at www.nature.com/articles/s41...

#antivenom #snakebite #NTD #nanobody

Modern biotech can deliver safer, scalable & affordable treatments for snakebite - a neglected tropical disease killing 100k+ people annually.
#Biotechnology #Snakebite #Nanobody #Antivenom #GlobalHealth #NTD
@blslancasteruni.bsky.social

Tomorrow, come learn about ways to accelerate your research!
#Omics #Nanobody #Bioinnovation #ResearchTools

Identification and non-clinical characterization of SAR444200, a novel anti-GPC3 NANOBODY® T-cell engager, for the treatment of GPC3+ solid tumors Abstract. T-cell engager (TCE) immunotherapy has demonstrated significant clinical activity in multiple cancers by inducing co-engagement of T-cells and tumor cells, resulting in T-cell activation and...

New #paper on using #nanobody to engage #Tcells to fight #cancer utilized our CMCF beamline. Read "Preclinical study of a novel NANOBODY®-based TCE SAR444200" by Sanofi and Astrazeneca at aacrjournals.org/mct/article/doi/10.1158/... 👈

Nanobody Market Size, Growth, Trends, Report 2035 Nanobody Market will grow at 17.88% CAGR to reach USD 2.94 billion by 2035 owing to Growing number of clinical trials of various nanobody products and Increasing prevalence of cancer and other chronic...

🧬 Discover how Nanobodies are redefining precision medicine! From diagnostics to therapy, this market is set for strong growth ahead. Read full insights: www.marketresearchfuture.com/reports/nano... #Nanobody #Biotech #HealthcareInnovation

Nanobody Market Size, Growth, Trends, Report 2032 Nanobody Market will grow at 17.88% CAGR to reach USD 2.94 billion by 2032 owing to Growing number of clinical trials of various nanobody products and Increasing prevalence of cancer and other chronic...

🧫 The Nanobody Market is gaining traction for diagnostics, oncology & immunotherapy.
Key players:
🔹 @AblynxNV
🔹 @Sanofi
🔹 @Merck

#Nanobody #Immunotherapy #Biotech #Diagnostics #PharmaInnovation #MRFR

www.marketresearchfuture.com/reports/nano...

🧪 August’s most-read Biochemistry paper presents an alternative platform for #nanobody discovery using phage-displayed synthetic libraries: buff.ly/cXOdjHd

Have a paper people should see? See what our Editors look for: buff.ly/o2u0B4k

🆕 Looking for a reliable reagent for efficient human B-cell stimulation?

Meet NanoTag’s Human B-cell Activator (hBCA): tetramerized sdAb for fast, consistent, Fc-free B-cell activation.

👉 Learn more here: bit.ly/3KldYMF

#Immunology #BCRclustering #Nanobody

Mit „Nanobodies“ gegen Herpes Aus für Lippenbläschen und Genitalherpes? Ein neu entwickelter Mini-Antikörper kann das Herpesvirus neutralisieren – schon bevor die Infektion ausbricht. Der Nanobody blockiert einen Bereich der Virenhülle, der für das Eindringen in unsere Zellen essenziell ist. Dadurch kann das Herpesvirus die Zelle nicht mehr infizieren, wie Zellversuche ergaben. Sollte sich diese Wirkung auch in Tierversuchen bestätigen, wäre dies eine neue, breit wirksame Therapie gegen Herpes simplex.

Mit „Nanobodies“ gegen Herpes https://wp.me/p36Ae-1drN Aus für Lippenbläschen und Genitalherpes? Ein neu entwickelter Mini-Antikörper kann das Herpesvirus neutralisieren – schon bevor die Infektion ausbricht. #Herpessimplex #Virus #Miniantikörper #Nanobody

🔬 Attending #SMLMS25 in Bonn?

Don’t miss our CSO Dr. Steffen Frey on Wednesday Aug 27, 14:40, presenting #SmartSecondaries® – secondary sdAb-based reagents enabling OneStep-IF and Species-Independent #Multiplexing.

🦙 Come by at the NanoTag booth for a chat!

#SuperResolution #Microscopy #Nanobody

Computational nanobody design through deep generative modeling and epitope landscape profiling. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.07.052

🤖 Can algorithms outsmart evolution to create therapies humans never imagined?

🔗 Computational nanobody design through deep generative modeling and epitope landscape profiling. DOI: doi.org/10.1016/j.cs...

📚 CSBJ: www.csbj.org

#AntibodyEngineering #Nanobody #ProteinDesign #DrugDiscovery @csbj.org

Empowering Nanoscopy with single-domain antibodies_NanoTag Biotechnologies_SMLM2025

🔬 Two weeks to go until the 14th #SMLM2025 @smlm-symposium.bsky.social! NanoTag joins as Gold Sponsor to support this unique #SuperResolution community event. Don't miss our CSO Dr. Steffen Frey talk on Smart Secondaries® (27 Aug, 14:40) or meet him at the #NanoTag booth 🦙. #Nanobody #Multiplexing